Current management of brain metastases;Traitement actuel des métastases cérébrales

Revue Neurologique

Volumn 164, Issue 6-7, 2008, Pages 560-568

  Guillamo, J S ^a   Emery, E ^a   Busson, A ^b   Lechapt Zalcman, E ^a   Constans, J M ^a   Defer, G L ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b CENTRE FRANÇOIS BACLESSE   (France)

Author keywords

Chemotherapy; Corticosteroids; Multidisciplinary; Radiosurgery; Radiotherapy; Surgery

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; TETRACOSACTIDE;

BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; HUMAN; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PROGNOSIS; QUALITY OF LIFE; RADIOSURGERY; REVIEW; SEIZURE;

BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; NEOPLASM METASTASIS;

EID: 45949110314     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2008.03.009     Document Type: Review

References (81)

1. Alexander III E., Moriarty T.M., Davis R.B., et al. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 87 (1995) 34-40
2. Andrews D.W., Scott C.B., Sperduto P.W., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363 (2004) 1665-1672
3. Antonadou D., Paraskevaidis M., Sarris G., et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 20 (2002) 3644-3650
4. Aoyama H., Shirato H., Tago M., et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295 (2006) 2483-2491
5. Arbit E., Wronski M., Burt M., and Galicich J.H. The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancer. Cancer 76 (1995) 765-773
6. Auchter R.M., Lamond J.P., Alexander E., et al. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 35 (1996) 27-35
7. Berk L. An overview of radiotherapy trials for the treatment of brain metastases. Oncology (Huntingt) 9 (1995) 1205-1212
8. Bindal R.K., Sawaya R., Leavens M.E., and Lee J.J. Surgical treatment of multiple brain metastases. J Neurosurg 79 (1993) 210-216
9. Bokemeyer C., Nowak P., Haupt A., et al. Treatment of brain metastases in patients with testicular cancer. J Clin Oncol 15 (1997) 1449-1454
10. Boogerd W., Dalesio O., Bais E.M., and van der Sande J.J. Response of brain metastases from breast cancer to systemic chemotherapy. Cancer 69 (1992) 972-980
11. Byrne T.N., Cascino T.L., and Posner J.B. Brain metastasis from melanoma. J Neurooncol 1 (1983) 313-317
12. Cairncross J.G., Kim J.H., and Posner J.B. Radiation therapy for brain metastases. Ann Neurol 7 (1980) 529-541
13. Chamberlain M.C. Leptomeningeal metastases: A review of evaluation and treatment. J Neurooncol 37 (1998) 271-284
14. Chen J.C., Petrovich Z., O'Day S., et al. Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Neurosurgery 47 (2000) 268-279
15. Coia L.R. The role of radiation therapy in the treatment of brain metastases. Int J Radiat Oncol Biol Phys 23 (1992) 229-238
16. Coia L.R., Aaronson N., Linggood R., Loeffler J., and Priestman T.J. A report of the consensus workshop panel on the treatment of brain metastases. Int J Radiat Oncol Biol Phys 23 (1992) 223-227
17. Davis P.C., Hudgins P.A., Peterman S.B., and Hoffman Jr. J.C. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast- enhanced MR imaging. AJNR Am J Neuroradiol 12 (1991) 293-300
18. DeAngelis L.M. Management of brain metastases. Cancer Invest 12 (1994) 156-165
19. DeAngelis L.M., Delattre J.Y., and Posner J.B. Radiation-induced dementia in patients cured of brain metastases. Neurology 39 (1989) 789-796
20. Deeken J.F., and Loscher W. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clin Cancer Res 13 (2007) 1663-1674
21. Delattre J.Y., Krol G., Thaler H.T., and Posner J.B. Distribution of brain metastases. Arch Neurol 45 (1988) 741-744
22. Delattre J.Y., Safai B., and Posner J.B. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 38 (1988) 194-198
23. Dupont S. Épilepsie et tumeurs cérébrales. Rev Neurol (Paris) 2008, 164
24. Flickinger J.C., Lunsford L.D., Somaza S., and Kondziolka D. Radiosurgery: its role in brain metastasis management. Neurosurg Clin N Am 7 (1996) 497-504
25. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37 (1997) 745-751
26. Gelber R.D., Larson M., Borgelt B.B., and Kramer S. Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis. Cancer 48 (1981) 1749-1753
27. Glantz M.J., Cole B.F., Forsyth P.A., et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54 (2000) 1886-1893
28. Glantz M.J., Cole B.F., Friedberg M.H., et al. A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 46 (1996) 985-991
29. Harwood A.R., and Simson W.J. Radiation therapy of cerebral metastases: a randomized prospective clinical trial. Int J Radiat Oncol Biol Phys 2 (1977) 1091-1094
30. Hazuka M.B., Burleson W.D., Stroud D.N., Leonard C.E., Lillehei K.O., and Kinzie J.J. Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy. J Clin Oncol 11 (1993) 369-373
31. Hazuka M.B., and Kinzie J.J. Brain metastases: results and effects of re-irradiation. Int J Radiat Oncol Biol Phys 15 (1988) 433-437
32. Helfre S., and Pierga J.Y. Radiothérapie et chimiothérapie des métastases cérébrales. Neurochirurgie 45 (1999) 382-392
33. Hoang-Xuan K., Delattre J.Y., and Poisson M. Stevens-Johnson syndrome in a patient receiving cranial irradiation and carbamazepine. Neurology 40 (1990) 1144-1145
34. Hoang-Xuan K, Napolitano M, Cornu P, Delattre JY. Métastases cérébrales et leptoméningées des cancers solides. In: Encycl Méd Chir (Elsevier, Paris), Neurologie 1999 17-255-A-10, 22 p.
35. Hwang T.L., Close T.P., Grego J.M., Brannon W.L., and Gonzales F. Predilection of brain metastasis in gray and white matter junction and vascular border zones. Cancer 77 (1996) 1551-1555
36. Kaal E.C., Niel C.G., and Vecht C.J. Therapeutic management of brain metastasis. Lancet Neurol 4 (2005) 289-298
37. Kehrli P. Épidémiologie des métastases cérébrales. Neurochirurgie 45 (1999) 357-363
38. Kondziolka D., Patel A., Lunsford L.D., Kassam A., and Flickinger J.C. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 45 (1999) 427-434
39. Khuntia D., Brown P., Li J., and Mehta M.P. Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24 (2006) 1295-1304
40. Kurup P., Reddy S., and Hendrickson F.R. Results of re-irradiation for cerebral metastases. Cancer 46 (1980) 2587-2589
41. Lagerwaard F.J., Levendag P.C., Nowak P.J., Eijkenboom W.M., Hanssens P.E., and Schmitz P.I. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43 (1999) 795-803
42. Lester S.G., Morphis II J.G., Hornback N.B., Williams S.D., and Einhorn L.H. Brain metastases and testicular tumors: need for aggressive therapy. J Clin Oncol 2 (1984) 1397-1403
43. Levin J.M., Schiff D., Loeffler J.S., Fine H.A., Black P.M., and Wen P.Y. Complications of therapy for venous thromboembolic disease in patients with brain tumors. Neurology 43 (1993) 1111-1114
44. Loeffler J.S., Kooy H.M., Wen P.Y., et al. The treatment of recurrent brain metastases with stereotactic radiosurgery. J Clin Oncol 8 (1990) 576-582
45. Maor M.H., Dubey P., Tucker S.L., et al. Stereotactic radiosurgery for brain metastases: results and prognostic factors. Int J Cancer 90 (2000) 157-162
46. Mehta M.P., Rodrigus P., Terhaard C.H., et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21 (2003) 2529-2536
47. Merchut M.P. Brain metastases from undiagnosed systemic neoplasms. Arch Intern Med 149 (1989) 1076-1080
48. Mintz A.H., Kestle J., Rathbone M.P., et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 78 (1996) 1470-1476
49. Nguyen L.N., Maor M.H., and Oswald M.J. Brain metastases as the only manifestation of an undetected primary tumor. Cancer 83 (1998) 2181-2184
50. Noordijk E.M., Vecht C.J., Haaxma-Reiche H., et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 29 (1994) 711-717
51. Nussbaum E.S., Djalilian H.R., Cho K.H., and Hall W.A. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 78 (1996) 1781-1788
52. Nutt S.H., and Patchell R.A. Intracranial hemorrhage associated with primary and secondary tumors. Neurosurg Clin N Am 3 (1992) 591-599
53. Patel R.R., and Mehta M.P. Targeted therapy for brain metastases: improving the therapeutic ratio. Clin Cancer Res 13 (2007) 1675-1683
54. Patchell R.A., Tibbs P.A., Regine W.F., et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280 (1998) 1485-1489
55. Patchell R.A., Tibbs P.A., Walsh J.W., et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322 (1990) 494-500
56. Paterson A.H., Agarwal M., Lees A., Hanson J., and Szafran O. Brain metastases in breast cancer patients receiving adjuvant chemotherapy. Cancer 49 (1982) 651-654
57. Pors H., von Eyben F.E., Sorensen O.S., and Larsen M. Longterm remission of multiple brain metastases with tamoxifen. J Neurooncol 10 (1991) 173-177
58. Posner J.B. Management of brain metastases. Rev Neurol (Paris) 148 (1992) 477-487
59. Posner J.B. Brain metastases: 1995. A brief review. J Neurooncol 27 (1996) 287-293
60. Postmus P.E., and Smit E.F. Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol 10 (1999) 753-759
61. Rudà R., Borgognone M., Benech F., Vasario E., and Soffietti R. Brain metastases from unknown primary tumour: a prospective study. J Neurol 248 (2001) 394-398
62. Sawaya R., Zuccarello M., Elkalliny M., and Nishiyama H. Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile. J Neurooncol 14 (1992) 119-125
63. Schiff D., and DeAngelis L.M. Therapy of venous thromboembolism in patients with brain metastases. Cancer 73 (1994) 493-498
64. Shaw E., Scott C., Souhami L., et al. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys 34 (1996) 647-654
65. Stewart D.J. A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors. J Neurooncol 20 (1994) 121-139
66. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
67. Sundaresan N., Sachdev V.P., DiGiacinto G.V., and Hughes J.E. Reoperation for brain metastases. J Clin Oncol 6 (1988) 1625-1629
68. Suh J.H., Stea B., Nabid A., et al. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol 24 (2006) 106-114
69. Swift P.S., Phillips T., Martz K., et al. CT characteristics of patients with brain metastases treated in RTOG study 79-16. Int J Radiat Oncol Biol Phys 25 (1993) 209-214
70. Sze G., Milano E., Johnson C., and Heier L. Detection of brain metastases: comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 11 (1990) 785-791
71. Tendulkar R.D., Liu S.W., Barnett G.H., et al. RPA classification has prognostic significance for surgically resected single brain metastasis. Int J Radiat Oncol Biol Phys 66 (2006) 810-817
72. van de Pol M., van Aalst V.C., Wilmink J.T., and Twijnstra A. Brain metastases from an unknown primary tumour: which diagnostic procedures are indicated?. J Neurol Neurosurg Psychiatry 61 (1996) 321-323
73. Vecht C.J. Clinical management of brain metastasis. J Neurol 245 (1998) 127-131
74. Vecht C.J., Haaxma-Reiche H., Noordijk E.M., et al. Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?. Ann Neurol 33 (1993) 583-590
75. Verger E., Gil M., Yaya R., et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys 61 (2005) 185-191
76. Vogelbaum M.A., and Suh J.H. Resectable brain metastases. J Clin Oncol 24 (2006) 1289-1294
77. Weinstein J.D., Toy F.J., Jaffe M.E., and Goldberg H.I. The effect of dexamethasone on brain edema in patients with metastatic brain tumors. Neurology 23 (1973) 121-129
78. Weissman D.E. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J Clin Oncol 6 (1988) 543-551
79. Wen P.Y., and Loeffler J.S. Management of brain metastases. Oncology (Huntingt) 13 (1999) 941-954
80. Wong W.W., Schild S.E., Sawyer T.E., and Shaw E.G. Analysis of outcome in patients reirradiated for brain metastases. Int J Radiat Oncol Biol Phys 34 (1996) 585-590
81. Zimm S., Wampler G.L., Stablein D., Hazra T., and Young H.F. Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer 48 (1981) 384-394